-
EP3538553
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3538553
| EP3538553 - ANTI-SECRETOGRANIN III (SCG3) ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 01.03.2024 Database last updated on 30.03.2026 | |
| Former | Request for examination was made Status updated on 16.08.2019 | ||
| Former | The international publication has been made Status updated on 19.05.2018 | Most recent event Tooltip | 08.01.2026 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states University of Miami 1951 NW 7th Avenue Miami, FL 33136 / US | [2019/38] | Inventor(s) | 01 /
LI, Wei 9177 SW 72nd Avenue Apt. L-8 Miami, FL 33156 / US | 02 /
LEBLANC, Michelle, E. 1 Taft Circle Millbury, MA 01527 / US | 03 /
WANG, Weiwen 11560 SW 81st Terrace Miami, FL 33173 / US | 04 /
ROSENFELD, Philip, J. 900 NW 17th Street Miami, FL 33136 / US | [2019/38] | Representative(s) | Inspicos P/S Strandvejen 60 2900 Hellerup / DK | [N/P] |
| Former [2019/38] | Inspicos P/S Kogle Allé 2 2970 Hørsholm / DK | Application number, filing date | 17870298.1 | 06.11.2017 | [2019/38] | WO2017US60189 | Priority number, date | US201662419195P | 08.11.2016 Original published format: US 201662419195 P | [2019/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018089305 | Date: | 17.05.2018 | Language: | EN | [2018/20] | Type: | A1 Application with search report | No.: | EP3538553 | Date: | 18.09.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.05.2018 takes the place of the publication of the European patent application. | [2019/38] | Search report(s) | International search report - published on: | US | 17.05.2018 | (Supplementary) European search report - dispatched on: | EP | 26.10.2020 | Classification | IPC: | C07K16/22, C12P21/08, A61P35/00, A61P27/02, // A61K39/00 | [2020/30] | CPC: |
A61P27/02 (EP,US);
C07K16/22 (EP,US);
A61K9/0019 (US);
A61K9/0048 (US);
A61P35/00 (EP);
A61K2039/505 (EP);
|
| Former IPC [2019/38] | C07K16/00, C12P21/08 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/38] | Title | German: | ANTI-SECRETOGRANIN III (SCG3)-ANTIKÖRPER UND VERWENDUNGEN DAVON | [2019/38] | English: | ANTI-SECRETOGRANIN III (SCG3) ANTIBODIES AND USES THEREOF | [2019/38] | French: | ANTICORPS ANTI-SÉCRÉTOGRANINE III (SCG3) ET LEURS UTILISATIONS | [2019/38] | Entry into regional phase | 11.06.2019 | National basic fee paid | 11.06.2019 | Search fee paid | 11.06.2019 | Designation fee(s) paid | 11.06.2019 | Examination fee paid | Examination procedure | 11.06.2019 | Examination requested [2019/38] | 21.05.2021 | Amendment by applicant (claims and/or description) | 04.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 14.11.2019 | Renewal fee patent year 03 | 13.11.2020 | Renewal fee patent year 04 | 19.10.2021 | Renewal fee patent year 05 | 13.10.2022 | Renewal fee patent year 06 | 11.10.2023 | Renewal fee patent year 07 | 27.11.2024 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.11.2025 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] WO2006010532 (HOFFMANN LA ROCHE et al.) [X] 1 * abstract * * example 3 * * page 2, line 1 - line 4 *[I] 2-14 | [XI] WO2014014819 (NGM BIOPHARMACEUTICALS INC et al.) [X] 1 * claims 10, 19, 47 * * sequences 53, 54 *[I] 2-14 | [XI] SAKAI Y ET AL: "Immunocytochemical localization of secretogranin III in the endocrine pancreas of male rats", ARCHIVES OF HISTOLOGY AND CYTOLOGY, JAPAN SOCIETY OF HISTOLOGICAL DOCUMENTATION, NIIGATA, JP, vol. 67, no. 1, 1 March 2004 (2004-03-01), pages 57 - 64, XP002351525, ISSN: 0914-9465, DOI: 10.1679/AOHC.67.57 [X] 1 * page 58, paragraph 3 * * page 60; figure 3 * * page 61; figure 4 * [I] 2-14 DOI: http://dx.doi.org/10.1679/aohc.67.57 | [XI] WANG YUE ET AL: "The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells", CANCER LETTERS, NEW YORK, NY, US, vol. 352, no. 2, 29 May 2014 (2014-05-29), pages 169 - 178, XP029046182, ISSN: 0304-3835, DOI: 10.1016/J.CANLET.2014.05.007 [X] 1 * abstract * * page 169, column r, paragraph 3 * * figures 6A, 6B *[I] 2-15 DOI: http://dx.doi.org/10.1016/j.canlet.2014.05.007 | [XI] PORTELA-GOMES G M ET AL: "Secretogranin III in human neuroendocrine tumours", REGULATORY PEPTIDES, ELSEVIER SCIENCE BV, NL, vol. 165, no. 1, 30 November 2010 (2010-11-30), pages 30 - 35, XP027547334, ISSN: 0167-0115, [retrieved on 20100612] [X] 1 * abstract * * page 32, column l, paragraph 7 *[I] 2-14 | International search | [A] WO2010078526 (BIOGEN IDEC INC et al.) [A] 1-4, 7-10, 17/(1-4, 7-9), 39/(1-4, 7-10) * pg 124, antibody VH CDR1 #7, GYVFSSSWMN * | [A] WO2015184207 (MACROGENICS INC et al.) [A] 1-4, 7-10, 17/(1-4, 7-9), 39/(1-4, 7-10) | [A] ROZEK ET AL.: "Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells", TUMOUR BIOL, vol. 34, no. 3, 2013, pages 1773 - 81, XP055482851 [A] 1-4, 7-10, 17/(1-4,7-9), 39/(1-4,7-10) * ; pg 1774, col 2 * DOI: http://dx.doi.org/10.1007/s13277-013-0716-0 |